Blockbuster biotech deal coming?

CNBC's Meg Tirrell reports the latest on Gilead. Geoff Porges, Leerink Partners managing director and senior biotech analyst, weighs in.

from Mergers and Acquisitions http://ift.tt/2dqrkrk